The relevance of residence time theory to pharmacokinetics

European Journal of Clinical Pharmacology
M Weiss

Abstract

No abstract listed.

References

Aug 1, 1978·The Journal of Pharmacy and Pharmacology·D J Cutler
Aug 1, 1979·Journal of Pharmaceutical Sciences·L Z Benet, R L Galeazzi
Dec 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K YamaokaT Uno
Dec 1, 1978·Canadian Journal of Physiology and Pharmacology·M A Kallai-SanfaçonG Steiner
May 1, 1975·British Journal of Obstetrics and Gynaecology·J M KjeldT R Fraser
Aug 1, 1992·Biopharmaceutics & Drug Disposition·I D Cockshott, J Haywood
Aug 1, 1992·Computers and Biomedical Research, an International Journal·G E Dallal, P J Rousseeuw
Jun 1, 1992·Journal of Pharmacokinetics and Biopharmaceutics·M Weiss, K S Pang
Jan 1, 1990·Pharmaceutical Research·H Y Cheng, W J Jusko
Mar 1, 1990·Biopharmaceutics & Drug Disposition·M D Karol
Jan 1, 1987·European Journal of Clinical Pharmacology·V K Piotrovskii
Oct 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·N Watari, L Z Benet
Dec 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·K C Yeh, R D Small
Feb 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·A Dunne, P King
Jan 1, 1989·Clinical Pharmacology and Therapeutics·T K HenthornT C Krejcie
Aug 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·P Veng-Pedersen
Jan 1, 1988·Biopharmaceutics & Drug Disposition·J G Wagner
Jan 1, 1986·British Journal of Clinical Pharmacology·H Sheppeard, K G Couchman
Jan 1, 1987·Biopharmaceutics & Drug Disposition·D J Cutler
Jan 1, 1987·Journal of Pharmaceutical Sciences·E NakashimaA Tsuji
Jun 1, 1987·Journal of Pharmacokinetics and Biopharmaceutics·A Rescigno, J S Beck
Jan 1, 1986·European Journal of Clinical Pharmacology·E J Sainsbury, J J Ashley
Aug 1, 1986·Journal of Pharmacokinetics and Biopharmaceutics·K Kubota, T Ishizaki
Oct 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·E M Landaw, D Katz
Oct 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·W R Gillespie, P Veng-Pedersen
Oct 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·L Z Benet
Jan 1, 1985·European Journal of Clinical Pharmacology·D Brockmeier, J Ostrowski
Feb 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·D O Chanter
Oct 7, 1985·Journal of Theoretical Biology·M Weiss
Jan 1, 1984·Drug Metabolism Reviews·E A Nüesch
Jan 1, 1984·European Journal of Clinical Pharmacology·G T TuckerD W Holt
Apr 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·M Weiss
Aug 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·C GraffnerJ E Lindgren
Jan 1, 1983·European Journal of Clinical Pharmacology·M Weiss
Aug 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio, D Katz
Feb 1, 1984·Journal of Pharmaceutical Sciences·I L Smith, J J Schentag
Jan 1, 1983·European Journal of Clinical Pharmacology·V W Steinijans, E Diletti
Feb 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·M Weiss

❮ Previous
Next ❯

Citations

Jan 26, 2002·European Journal of Drug Metabolism and Pharmacokinetics·O KuhlmannM Weiss
Mar 23, 1999·Pharmaceutica acta Helvetiae·M S Rodríguez CruzM L Sayalero Marinero
Dec 10, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M Weiss
Oct 27, 2001·British Journal of Clinical Pharmacology·J LötschG Geisslinger
Dec 30, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Michael Weiss
Dec 1, 1995·Journal of Pharmacokinetics and Biopharmaceutics·M Looby, M Weiss
Jul 15, 1998·Clinical Pharmacology and Therapeutics·J LötschG Geisslinger
Oct 1, 1994·The International Journal of Clinical and Experimental Hypnosis·R J Ofshe, M T Singer
Mar 26, 1999·Journal of Biopharmaceutical Statistics·H J Heikkilä
Feb 6, 2017·Journal of Pharmacokinetics and Pharmacodynamics·Michael Weiss
May 15, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Pilar HerreroRobert Gropler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.